chevron_left Categories

Other related webinars

US FDA Regulations: Food, Drugs, Biologics and M...

Friday, 9th December, 2011
Time : 02:00 PM | 11:00 AM

FDA GLP compliance in conducting non-clinical re...

Friday, 13th January, 2012
Time : 02:00 PM EST | 11:00 AM PST

FDA BIMO Inspection: Do's and Don'ts

Friday, 24th February, 2012
Time : 02:00 PM EST | 11:00 AM PST

FDA Compliant Practice for Labeling and Off-Labe...

Friday, 30th March, 2012
Time : 02:00 PM EST | 11:00 AM PST

FDA Compliant Good Laboratory Practice (GLP) For...

Friday, 11th May, 2012
Time : 02:00 PM EST | 11:00 AM PST

Conducting Successful FDA Meetings

Friday, 19th April, 2013
Time : 01:00 PM EST | 10:00 AM PST

Best Practices for Preparation for, Behavior dur...

Friday, 5th December, 2014
Time : 01:00 PM EST | 10:00 AM PST

Understanding the Mindset of an FDA Employee

Thursday, 2nd April, 2015
Time : 11:30 AM EDT | 04:30 PM CET

FDA's Import Requirements and Managing the Impor...

Friday, 24th April, 2015
Time : 11:30 AM EDT | 04:30 PM CET

UDI and GUDID - The Unique Device Identification...

Friday, 8th May, 2015
Time : 01:00 PM EST | 10:00 AM PST

Good Distribution Practices

Friday, 26th June, 2015
Time : 02:00 PM EST | 11:00 AM PST

Premarket and Postmarket Data Collection - A Fas...

Friday, 28th August, 2015
Time : 01:00 PM EDT | 10:00 AM PDT

FDA’s ‘Refuse to Accept’ Process for 510(k...

Friday, 30th October, 2015
Time : 02:00 PM EDT | 11:00 AM PDT

FDA Medical Device Regulation – Effective Cor...

Wednesday, 9th December, 2015
Time : 02:00 PM EDT | 11:00 AM PDT

Protecting Patient Privacy

Monday, 25th April, 2016
Time : 01:00 PM EDT | 10:00 AM PDT

Best Practices for FDA Inspection: Preparation, ...

Friday, 27th May, 2016
Time : 01:00 PM EST | 10:00 AM PST

Navigating FDA Import Requirements for Food, Dev...

Friday, 3rd March, 2017
Time : 01:00 PM EST | 10:00 AM PST

FDA Warning Letter, FDA-483's and Import Alerts ...

Friday, 13th October, 2017
Time : 01:00 PM EST | 10:30 AM PST

A Bulletproof, Cost-efficient Supplier Managemen...

Friday, 12th January, 2018
Time : 01:00 PM EDT | 10:00 AM PDT

FDA Good Clinical Practice (GCP) for Drugs, Biol...

Friday, 8th June, 2018
Time : 01:00 PM EST | 10:00 AM PST

FDA Case Scenarios – Best Practices for Managi...

Friday, 14th December, 2018
Time : 01:00 PM EDT | 10:00 AM PDT

Registries - The latest FDA trends, Reducing Cos...

Friday, 26th June, 2020
Time : 01:00 PM EST | 10:00 AM PST

CAPA and Critical Documentation of Clinical Tria...

Friday, 7th May, 2021
Time : 01:00 PM EST | 10:00 AM PST

Fellowship in Clinical Cardiology

Thursday, 4th November, 2021
Time : 01:00 PM EST | 10:00 AM PST

Fellowship in 2D Echocardiography – Edition II...

Friday, 7th January, 2022
Time : 01:00 PM EST | 10:00 AM PST

FDA and Medical Device Advertising in the 21st C...

Friday, 20th January, 2023
Time : 01:00 PM EST | 10:00 AM PST

Capturing Justifications in Change Control, Risk...

Friday, 27th January, 2023
Time : 01:00 PM EST | 10:00 AM PST

FDA Good Clinical Practice and More! HOW TO PLAN...

Friday, 10th February, 2023
Time : 01:00 PM EST | 10:00 AM PST

How FDA Trains Its Investigators to Review CAPA,...

Friday, 31st March, 2023
Time : 01:00 PM EST | 10:00 AM PST

How FDA Evaluates Your Quality Management System...

Thursday, 22nd February, 2024
Time : 01:00 PM EST | 10:00 AM PST

Recorded Webinar

FDA Compliant Practice for Labeling and Off-Label Promotion: What Is Acceptable to FDA and Not Acceptable?

timelapse 60 mins with 10-15 mins of Q and A

Note:

This webinar occured in the past
Along with recorded webinar, copy of presentation slides will be shared
Recorded Webinar can be played unlimited times

Speaker/Presenter

Short Abstract

This webinar is intended to discuss the FDA-compliant practices for disseminating off-label information by firms for their FDA-approved or cleared products (drugs for both human and animals and medical devices for humans) and in particular, how to respond to both non-public and public unsolicited requests made through emerging electronic media (e.g., social media or other public electronic media).

At the end of the webinar, you will get empowered in a way how you would plan, develop and disseminate medical information including off-label information via the various social media.

The presentation will cover the following areas:

  • Review of relevant and applicable statutory provisions.
  • Review of implementing FDA regulations.
  • Discuss label and labeling within the meaning and scope compliant with FDA’s current thinking.
  • Discuss the differences between the solicited requests and unsolicited requests for off-label information.
  • Discuss the differences between public unsolicited requests and non-public unsolicited requests.
  • Discuss how to disseminate off-label information to the public in a manner acceptable.
  • Discuss how to respond to non-public or public unsolicited requests for off-label information about FDA-approved or cleared products (drugs and medical devices) (e.g., requests made through social media or other public electronic media).
  • Discuss FDA’s current recommendations to firms wishing to respond to unsolicited requests for off-label information.
  • Discuss the best practices for disseminating off-label information responding to public and non-public unsolicited requests.
  • What is acceptable and not acceptable?
  • Discuss who should and should not respond to the non-public and public unsolicited requests for off label information and how to respond.
  • Discuss the nature of the Petition filed on behalf of several drug manufacturers regarding how to disseminate “off-label” information.
  • Recent enforcement actions
  • Speaker’s practical, actionable and strategic solutions to disseminate off-label information: “CAC-SI” method


Apply for this webinar

Who should attend

Anyone who is interested to learn more on FDA Compliant Practice for Labeling and Off-Label Promotion

Content Disclaimer

Contents in our website are from external websites. Links to and content from external website are provided for the convenience of users. Biopractice.com takes no responsibility for the content of such links and websites.

//